Celularity Inc (CELU): Entry into a Material Definitive Agreement
Celularity Inc (CELU) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 LOAN agreement This Loan Agreement, dated as of June 29, 2026 (“ Agreement ”), is among Celularity Inc., a Delaware corporation (the “ Borrower ”), and Philip & Daniele Barach Family Trust (the “ Lender ” and, together with the Borrower,
How this was made
The 30-second read
Why it matters
The disclosed loan facility creates new debt service obligations and introduces a higher penalty interest rate (18%) during an event of default, which can influence perceived liquidity and credit risk.
Market read
Traders can reassess CELU’s near-term financing/liquidity risk based on the newly disclosed loan terms and default pricing.
What to watch
Key missing terms (maturity date, covenants, collateral/security, and proceeds use) could materially change credit risk; default interest alone may overstate impact without those details.
Background
The filing is an SEC Form 8-K reporting entry into a material definitive agreement, including a direct financial obligation (loan) and related officer/director compensatory arrangements (Item 5.02).
Ticker impact
Celularity entered a $1,000,000 loan agreement with 4.0% interest, with default interest jumping to 18.0% and repayment tied to a subsequent transaction.
Likely modest, liquidity/risk-focused reaction; direction depends on whether the loan signals funding stress versus opportunistic capital.
This is a primary SEC filing with concrete debt terms, but the principal size ($1.0m) is relatively small and the excerpt lacks maturity, covenants, and use-of-proceeds details.
Market effects
Adds a datapoint on small-cap biotech financing via related-party/individual lender structures; limited direct sector read-across from this excerpt.
No clear regional spillover indicated.
No global macro or cross-border transaction details provided in the excerpt.
Counterpoint
The loan could be a short-term bridge on favorable terms (4% stated rate) rather than distress, especially if repayment is triggered by an upcoming transaction.
Key entities
- issuerCelularity Inc
Borrower that entered a $1,000,000 loan agreement disclosed in the 8-K.
- lenderPhilip & Daniele Barach Family Trust
Lender providing the $1,000,000 loan under the agreement.
